Your session is about to expire
← Back to Search
Mailed FIT for Colorectal Cancer (SCORE Trial)
SCORE Trial Summary
This trial will test whether mailing fecal immunochemical tests (FITs) to adults ages 45-75 will increase colorectal cancer (CRC) screening rates. The study will be implemented in two age groups: 45-49 years and 50-75 years.
SCORE Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSCORE Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.SCORE Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I haven't had any major colon tests in the last 5-10 years.I had an abnormal stool test result in the study's first round.I have had a recent colon cancer screening test.I have been diagnosed with colorectal cancer or have had my entire colon removed.I am between 45 and 75 years old.I do not have dementia, end-stage kidney disease, or live in assisted living/hospice care. I also don't have certain other cancers.I do not have dementia, am not in hospice care, do not live in assisted living, and do not have end-stage renal disease or other specified cancers.I have visited the clinic within the last 18 months.I haven't visited the clinic in the last 18 months.I have never been diagnosed with colorectal cancer or had my entire colon removed.You have a normal risk for colorectal cancer (CRC).I am either under 45 or over 75 years old.
- Group 1: Trial Usual Care - Age Group 50-75
- Group 2: Sub-study Mailed FIT Intervention Enhanced Envelope - Age Group 45-49
- Group 3: Trial Mailed FIT Intervention - Age Group 50-75
- Group 4: Sub-study Mailed FIT Comparator Plain Envelope - Age Group 45-40
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Who can be part of this research endeavor?
"This research endeavour seeks to enrol 4,400 individuals between 45 and 75 years of age who have colorectal cancer. Furthermore, these participants must meet additional criteria including: having an average risk for CRC (defined as lacking any history or record of colonic adenomas/polyps), not having undergone FOBT/FIT nor a CT Colonography within the past 12 months and 10 years respectively; no records indicating comorbidities such as dementia, end-stage renal disease etc.; being actively registered at the clinic that is conducting this trial; providing a valid North carolina mailing address in their medical records; and lastly"
What purpose does this experiment seek to accomplish?
"This clinical trial has two primary goals that will be monitored over a period of six months. The first is to ascertain the proportion of participants aged 50-75 who complete colorectal cancer screening within this timeframe, and the second is to measure the incremental cost associated with each additional patient screened in comparison to usual care. Secondary objectives include ascertaining what percentage of those with abnormal FIT/FOBT results receive follow up colonoscopies, as well as quantifying how many people are referred for cancer treatment post diagnosis through electronic health records review."
Is there availability to join this research project at present?
"The data posted on clinicaltrials.gov suggests that this trial is no longer seeking participants, as the last update was made over a year ago. Nevertheless, there are still 1,064 other trials open to prospective candidates at present."
Does this clinical trial accommodate individuals aged 40 and above?
"The accepted age range for this medical trial is between 45 and 75 years old. There are a total of 38 trials available to those under 18, while 1050 studies can be found that focus on patients aged 65 or older."
Share this study with friends
Copy Link
Messenger